[1] Abbott BD, Schmid JE, Brown JG, et al. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone [J]. Toxicol Sci, 1999, 47(1): 76-85. [2] Birnbaum LS. Developmental effects of dioxins and related endocrine disrupting chemicals[J]. Toxicol Lett, 1995, 82-83: 743-750. [3] Gao Z, Bu Y, Liu X, et al. TCDD promoted EMT of hFPECs via AhR, which involved the activation of EGFR/ERK signaling [J]. Toxicol Appl Pharmacol, 2016, 298: 48-55. [4] Chopra M, Schrenk D. Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death [J]. Crit Rev Toxicol, 2011, 41(4): 292-320. [5] Harris C, Dixon M, Hansen JM. Glutathione depletion modulates methanol, formaldehyde and formate toxicity in cultured rat conceptuses [J]. Cell Biol Toxicol, 2004, 20(3): 133-145. [6] Birnbaum LS, Harris MW, Miller CP, et al. Synergistic interaction of 2,3,7,8,-tetrachlorodibenzo-p-dioxin and hydrocortisone in the induction of cleft palate in mice [J]. Teratology, 1986, 33(1): 29-35. [7] Pratt RM, Dencker L, Diewert VM. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion [J]. Teratog Carcinog Mutagen, 1984, 4(5): 427-436. [8] Yamada T, Mishima K, Fujiwara K, et al. Cleft lip and palate in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: a morphological in vivo study[J]. Congenit Anom (Kyoto), 2006, 46(1): 21-25. [9] Fujiwara K, Yamada T, Mishima K, et al. Morphological and immunohistochemical studies on cleft palates induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice [J]. Congenit Anom (Kyoto), 2008, 48(2): 68-73. [10] Wells PG, Lee CJ, McCallum GP, et al. Receptor- and reactive intermediate-mediated mechanisms of teratogenesis [J]. Handb Exp Pharmacol, 2010, (196): 131-162. [11] Jang JY, Shin S, Choi BI, et al. Antiteratogenic effects of alpha-naphthoflavone on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposed mice in utero [J]. Reprod Toxicol, 2007, 24(3-4): 303-309. [12] Yuan X, He X, Zhang X, et al. Comparative study of folic acid and alpha-naphthoflavone on reducing TCDD-induced cleft palate in fetal mice[J]. Cleft Palate Craniofac J, 2017, 54(2): 216-222. [13] Kawajiri K, Fujii-Kuriyama Y. Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor [J]. Arch Biochem Biophs, 2007, 464(2): 207-12. [14] Reichard JF, Dalton TP, Shertzer HG, et al. Induction of oxidative stress responses by dioxin and other ligands of the aryl hydrocarbon receptor [J]. Dose Response, 2006, 3(3): 306-331. [15] Ilavarasi K, Chermakani P, Arif Nisha S, et al. Antioxidant compounds in the seaweed Gelidiella acerosa protects human peripheral blood mononuclear cells against TCDD induced toxicity [J]. Drug Chem Toxicol, 2015, 38(2): 133-144. [16] Hassoun EA, Walter AC, Alsharif NZ, et al. Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid [J]. Toxicology, 1997, 124(1): 27-37. [17] Yan J, Hales BF. Depletion of glutathione induces 4-hydroxynonenal protein adducts and hydroxyurea teratogenicity in the organogenesis stage mouse embryo [J]. J Pharmacol Exp Ther, 2006, 319(2): 613-621. [18] Cuervo R, Covarrubias L. Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis [J]. Development, 2004, 131(1): 15-24. |